Since the withdrawal of Vioxx, experts have debated whether other NSAIDs have similar cardiovascular risks
October 2006
Since the withdrawal of Vioxx, experts have debated whether other NSAIDs have similar cardiovascular risks.
Now several new studies are shedding more light.
Vioxx (rofecoxib) seems especially risky...even low doses increase heart attack risk. And this risk is seen shortly after starting the drug...not just after 18 months as originally thought.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote